Doctors look at the levels of each in your blood to monitor your multiple myeloma. In your pee, this marker is called the Bence-Jones protein. If the ratio of the two types of free light chains is ...

Stage 2 multiple myeloma is an intermediate phase. This means the blood test markers and cancer genetic markers fall between ...

providing local laboratories and/or routine hospital settings with an excellent level of detection of multiple myeloma markers, which could be described as pan-genomic technology on a human scale.

providing local laboratories and/or routine hospital settings with an excellent level of detection of multiple myeloma markers, which could be described as pan-genomic technology on a human scale.

Agency drug reviewers had questioned patient risk criteria and the efficacy endpoint used in a key trial supporting J&J's ...

Investigators from Hackensack Meridian John Theurer Cancer Center (JTCC)—part of the National Cancer Institute-designated Lombardi Comprehensive Cancer Center at Georgetown University—and Hackensack ...

In addition, patients with multiple myeloma who have elevated GPRC5D levels ... 2 “Therefore, GPRC5D is a promising marker for detecting tumor burden and is a reliable target for targeted ...

It allows for the visualization of all rearrangements and numerical anomalies of the samples in a single layer, providing local laboratories and/or routine hospital settings with an excellent level of ...

providing local laboratories and/or routine hospital settings with an excellent level of detection of multiple myeloma markers, which could be described as pan-genomic technology on a human scale.